ArticleProcesses (Basel, Switzerland)2020
Ultrasensitive Ti
Article in Processes (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 120 citations in OpenAlex.
- MXene-chitosan nanocomposites for structure interface and biofunctional applications in biosensing biocatalysis and regenerative biotechnology.Bioprocess and biosystems engineering · 2026Review
- Synthesis and advanced applications of MXene nanosheets in energy storage, EMI shielding, and biomedicine: a review.RSC advances · 2026Review
- MXene-based electrochemical sensors for cancer biomarker detection: current trends, challenges, and future directions.Mikrochimica acta · 2025Review
- Biomedical potentials of MXene-based self-powered wearable devices: the future of next-generation wearables.RSC advances · 2025Review
- The Future of Tumor Markers: Advancing Early Malignancy Detection Through Omics Technologies, Continuous Monitoring, and Personalized Reference Intervals.Biomolecules · 2025Review
- MXene and prostate cancer: is there promising news?Nanomedicine (London, England) · 2025Review
- Portable Amperometric Biosensor Enhanced with Enzyme-Ternary Nanocomposites for Prostate Cancer Biomarker Detection.Biosensors · 2024Article
- Sensing the Future-Frontiers in Biosensors: Exploring Classifications, Principles, and Recent Advances.ACS omega · 2024Review
- Recent advances in the application of MXenes for neural tissue engineering and regeneration.Neural regeneration research · 2024Review
- MXene-based electrochemical devices applied for healthcare applications.Mikrochimica acta · 2024Review
- Biomolecule-functionalized nanoformulations for prostate cancer theranostics.Journal of advanced research · 2023Review
- Amperometric Miniaturised Portable Enzymatic Nanobiosensor for the Ultrasensitive Analysis of a Prostate Cancer Biomarker.Journal of functional biomaterials · 2023Article
- Nurturing the marriages of urinary liquid biopsies and nano-diagnostics for precision urinalysis of prostate cancer.Smart medicine · 2023Review
- Two-dimensional TiJournal of nanobiotechnology · 2022Article
- MXene-Chitosan Composites and Their Biomedical Potentials.Micromachines · 2022Review
- Advances of MXenes; Perspectives on Biomedical Research.Biosensors · 2022Review
- New Polymeric Composites Based on Two-Dimensional Nanomaterials for Biomedical Applications.Polymers · 2022Review
- MXene (TiMaterials (Basel, Switzerland) · 2022Review
- An Enzymatic Biosensor for the Detection of D-2-Hydroxyglutaric Acid in Serum and Urine.Biosensors · 2022Article
- Advances in Medical Wearable Biosensors: Design, Fabrication and Materials Strategies in Healthcare Monitoring.Molecules (Basel, Switzerland) · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 2 countries.
Funding
Abstract
Two-dimensional layered nanomaterial Ti
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.